Immunology of Respiratory Viruses

  • R. Ganguly
  • R. H. Waldman
Part of the Comprehensive Immunology book series (COMIMUN, volume 9)


More than 80% of acute respiratory infections are caused by viruses. These viruses are wide in diversity and distribution (Table 1). Respiratory viruses are highly infectious and are easily spread in the community. At the present time, immunity derived from previous exposure is the only effective means by which to stop the spread of these agents.


Influenza Virus Respiratory Syncytial Virus Virus Vaccine Serum Antibody Respiratory Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Alford, R. H., Rossen, R. D., Butler, W. T., and Kasel, J. A., 1967, Neutralizing and hemagglutination-inhibi-tion activity of nasal secretions following experimental human infection with A2 influenza virus, J. Immunol. 98:724.PubMedGoogle Scholar
  2. Artenstein, M. S., Miller, W. S., Lawson, T. H., and Brandt, B. L., 1968, Large volume air sampling for meningococci and adenoviruses, Am. J. Epidemiol. 87:567.PubMedGoogle Scholar
  3. Banatvala, J. E., Anderson, T. B., and Reiss, B. B., 1964, Parainfluenza infections in the community, Br. Med. J. 1:537.PubMedCrossRefGoogle Scholar
  4. Blank, K. J., Freedman, H. A., and Lilly, F. T., 1976, T-lymphocyte response to Friend virus induced tumor cell lines in mice of strains congeneic at H-2, Nature (London) 260:250.CrossRefGoogle Scholar
  5. Bienenstock, J., Johnston, N., and Perey, D. V. E., 1973a, Bronchial lymphoid tissue. I. Morphological characteristics, Lab. Invest. 28:686.PubMedGoogle Scholar
  6. Bienenstock, J., Johnston, N., and Perey, D. Y. E., 1973b, Bronchial lymphoid tissue. II. Functional characteristics, Lab. Invest. 28:693.PubMedGoogle Scholar
  7. Bienenstock, J., Clancy, R. L., and Perey, D. Y. E., 1976, Bronchial Associated Lymphoid Tissue: Its Relationship to Mucosal Immunity in the Immunologic and Infectious Reactions in the Lung (C. Kirkpatrick and H. Y. Reynolds, eds.), Marcel Dekker, New York.Google Scholar
  8. Board, A. V. Jr., Kempf, J. E., and Hanson, R. J., 1957, Phagocytosis of influenza virus. I. In vitro observations, J. Immunol. 79:416.Google Scholar
  9. Bradburne, A. F., and Somerset, B. A., 1969, The propagation of “Coronaviruses” in tissue cultures, Arch. Gesamte Virusforsh. 28:133.CrossRefGoogle Scholar
  10. Buckland, F. E., Doggett, J. R., and Tyrrell, D. A. J., 1964, The specificity of the antibody response of human volunteers to certain respiratory viruses, J. Hyg. 62:115.CrossRefGoogle Scholar
  11. Burrows, W., 1973, Thy Myxovirus group. Chapter 37, pp. 895–925, Saunders, Philadelphia.Google Scholar
  12. Buscho, R. F., 1972, Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine, J. Immunol. 108:169.PubMedGoogle Scholar
  13. Butler, W. T., Rossen, R. D., and Waldmann, T. A., 1967, On the mechanism of appearance of immunoglobulin A in nasal secretions in man, J. Clin. Invest. 46:1773.CrossRefGoogle Scholar
  14. Bynoe, M. L., Hobson, D., Horner, J., Kipps, A., Schild, G. C., and Tyrrell, D. A. J., 1961, Inoculation of human volunteers with a strain of virus isolated from a common cold, Lancet 1:1194.PubMedCrossRefGoogle Scholar
  15. Cambridge, G., Mackenzie, J. S., and Keast, D., 1976, Cell-mediated immune response to influenza virus infections in mice, Infect. Immun. 13:36.PubMedGoogle Scholar
  16. Gate, T. R., Douglas, R. G., Jr., and Couch, R. B., 1961, Interferon and resistance to upper respiratory virus illness, Proc. Soc. Exp. Biol. Med. 131:631.Google Scholar
  17. Gate, T. R., Couch, R. B., and Johnson, K. M., 1964, Studies with rhinovirus in volunteers: Production of illness, effect of naturally acquired antibody and a demonstration of a protective effect not associated with serum antibody, J. Clin. Invest. 43:56.CrossRefGoogle Scholar
  18. Gate, T. R., Rossen, R. D., Douglas, R. G., Jr., Butler, W. T., and Couch, R. B., 1966, The role of nasal secretion and serum antibody in the rhinovirus common cold, Am. J. Epidemiol. 84:352.Google Scholar
  19. Chamberlain, D. W., Nopajaroonsri, C., and Simon, G. T., 1973, Ultrastructure of the pulmonary lymphoid tissue, Am. Rev. Res. Dis. 108:621.Google Scholar
  20. Chanock, R. M., Kim, W. H., Vargosko, A. J., Delave, A., Johnson, K. M., Gumming, C., and Parrott, R. H., 1961, Respiratory syncytial virus, J. Am. Med. Assoc. 176:647.CrossRefGoogle Scholar
  21. Chin, J., Magoffin, R. L., Shearer, L. A., Schieble, J. H., and Lennette, E. H., 1969, Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am. J. Epidemiol. 89:449.PubMedGoogle Scholar
  22. Clancy, R., and Bienenstock, J., 1974, The proliferative response of bronchus associated lymphoid tissue after local and systemic immunization, J. Immunol. 112:1997.Google Scholar
  23. Cohen, A. B., and Gold, W. M., 1975, Defense mechanism of the lung, Annu. Rev. Physiol. 37:325.PubMedCrossRefGoogle Scholar
  24. Couch, R. B., et al., 1963, Immunization with types 4and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 88:394.PubMedGoogle Scholar
  25. Couch, R. B., et al., 1966, Effect of route of inoculation on experimental respiratory viral disease in volunteers and evidence for airborne transmission, Bacteriol. Rev. 30:517.PubMedGoogle Scholar
  26. Couch, R. B., Knight, V., Douglas, R. G., Black, S. H., and Hamory, B. H., 1968, The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol. Trans. Am. Clin. Climatol. Assoc. 80:265.Google Scholar
  27. Couch, R. B., Knight, V., Gerone, P. J., Gate, T. R., and Douglas, R. G., 1969, Factors influencing response of volunteers to inoculation with coxsackie virus A type 21, Am. Rev. Respir. Dis. 99:24.PubMedGoogle Scholar
  28. Craig, S. W., and Cebra, J. J., 1971, Peyer’s patches: An enriched source of precursors for IgA-producing immunocytes in the rabbit, J. Exp. Med. 134:188.PubMedCrossRefGoogle Scholar
  29. Craighead, J. E., Meier, M., and Cooley, M. H., 1969, Pulmonary infection due to rhinovirus type 13, N. Engl. J. Med. 281:1403.PubMedCrossRefGoogle Scholar
  30. Dick, E. C., Blumer, C. R., and Evans, A. S., 1967, Epidemiology of infections with rhinovirus types 43 and 55 in a group of University of Wisconsin student families, Am. J. Epidemiol. 86:386.PubMedGoogle Scholar
  31. Doherty, P. C., and Zinkernagel, R. M., 1975, H-2 compatibility is required for T-cell mediated lysis of target cells infected with lymphocytic choriomeningitis virus, J. Exp. Med. 141:502.PubMedCrossRefGoogle Scholar
  32. Doherty, P. C., and Zinkernagel, R. M., 1976, Specific immune lysis of paramyxovirus infected cells by H-2 compatible thymus derived lymphocytes, Immunology 31:27.PubMedGoogle Scholar
  33. Doherty, P. C., Blanden, R. V., and Zinkernagel, R. M., 1976, Specificity of virus immune effector T-cells for H- 2k or G-2d compatible interactions: Implications for H-h antigen diversity. Transplant. Rev. 29:89.PubMedGoogle Scholar
  34. Douglas, R. G., Jr., Gate, T. R., Gerone, P. J., and Couch, R. B., 1966, Quantitative rhinovirus shedding patterns in volunteers. Am. Rev. Respir. Dis. 94:159.PubMedGoogle Scholar
  35. Douglas, R. G., Jr., Rossen, R. D., Butler, W. T., and Couch, R. R., 1967, Rhinovirus neutralizing antibody in tears, parotid saliva, nasal secretions and serum, J. Immunol. 99:297.PubMedGoogle Scholar
  36. Dowdle, W. R., Coleman, M. T., Schoenbaum, S. C., Mostow, S. R., Kaye, H. S., and Hiengolzer, J. C., 1971, Studies on inactivated influenza vaccines. III. Effect of subcutaneous dosage on antibody levels in nasal secretions and protection against natural challenge, in: D. H. Dayton (ed.) Conference on Secretory Immunologic System, Vero Beach, FL 1969. Bethesda MD, National Institute of Child Health and Human Development, (1971), pp. 113–127. U.S. Government Printing Office.Google Scholar
  37. Edmondson, W. P., et al., 1966, Immunization by selective infection with type 4 adenovirus grown in human diploid tissue culture. 11. Specific protective effect against epidemic disease, J. Am. Med. Assoc. 195:453.CrossRefGoogle Scholar
  38. Ennis, F. A., Martin, W. J., Verbonitz, M. H., and Butchko, G. M., 1977a, Specificity studies on cytotoxic thymus derived lymphocytes reactive with influenza virus infected cells: Evidence for dual recognition of H-2 and viral hemagglutinin antigens, Proc. Natl. Acad. Sci. USA 74:3006.PubMedCrossRefGoogle Scholar
  39. Ennis, F. A., Martin, W. J., and Verbowitz, M. W., 1977b, Hemagglutinin-specific cytotoxic T-cell response during influenza infection, J. Exp. Med. 146:893.PubMedCrossRefGoogle Scholar
  40. Evans, R., and Alexander, P., 1970, Mechanism of immunologically specific killing of tumor cells by macrophages, Nature (London) 236:168.CrossRefGoogle Scholar
  41. Fazekas de St. Groth, S., and Donnelley, M., 1950, Studies in experimental immunology of influenza. IV. The protection value of active immunization, Aust. J. Exp. Med. Sci. 28:61.CrossRefGoogle Scholar
  42. Fleet, W. F., Couch, R. B., Gate, T. R., and Knight, V., 1965, Homologous and heterologous resistance to rhinovirus common cold. Am. J. Epidemiol. 82:185.PubMedGoogle Scholar
  43. Fox, J. P., Brandt, C. C., Wassermann, F. E., Hall, C. E., Spigland, I., Kogan, A., and Elveback, L. R., 1969, The virus watch program: A continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: Virus excretion patterns, antibody response, efficiency of surveillance, patterns of infection, and relation to illness. Am. J. Epidemiol. 89:25.PubMedGoogle Scholar
  44. Foy, H. M., Cooney, M. K., and Hatlen, J. B., 1968, Adenovirus type 3 epidemic associated with intermittent chlorination of a swimming pool, Arch. Environ. Health 17:795.PubMedGoogle Scholar
  45. Fulginiti, V. A., Ellen, J. J., Sieber, O. F., Joyner, J. W., Minamitani, M., and Meiklejohn, G., 1969, Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine, Am. J. Epidemiol. 89:435.PubMedGoogle Scholar
  46. Gadol, N., Johnson, J. E., and Waldman, R. H., 1974, Respiratory tract cell-mediated immunity: Comparison of primary and secondary response, Infect. Immun. 9:858.PubMedGoogle Scholar
  47. Galasso, G. J., Tyenyar, F. J., Cate, T. R., Couch, R. B., Glezen, W. P., Gross, P. A., Kasel, J. A., Webster, R.G., and Wright, P. F., eds., 1977, Clinical studies of influenza vaccines—1976: A conference held at the National Institute of Health, Bethesda, Maryland, January 20–21, 1977, J. Infect. Dis. Suppl. 136:S341-S746.Google Scholar
  48. Galindo, B., and Myrvik, Q. N., 1970, Migratory response of granulomatous alveolar cells from BCG-sensitized rabbits, J. Immunol. 105:227.PubMedGoogle Scholar
  49. Ganguly, R., Ogra, P. L., Regas, S., and Waldman, R.H., 1973, Rubella immunization of volunteers via the respiratory tract. Infect. Immun. 8:497.PubMedGoogle Scholar
  50. Ganguly, R., Waldman, R. H., D’Alessandri, R., and Sutherland, G., 1977, Studies on oral adjuvants against murine salmonellosis, in: International Symposium on Secretory Immune System and Caries Immunity, University of Alabama, December 7–9, 1977 (J. McGhee and J. Mestecky, eds.). Plenum Press, New York.Google Scholar
  51. Gardner, P. S., and McQuillin, J., 1968, Application of immunofluorescent antibody technique in rapid diagnosis of respiratory syncytial virus infection, Br. Med. J. 3:340.PubMedCrossRefGoogle Scholar
  52. Ginsberg, H. S., et al., 1955, Relation of the new respiratory agents to acute respiratory diseases, Am. J. Public Health 45:915.CrossRefGoogle Scholar
  53. Glasky, A. E. H., Pfadenhauer, R., Settineri, A., and Ginsberg, T., 1975, Isoprinosine, a purine derivative: Metabolic, immunologic and antiviral effects, pp. 157–171, in:Combined Immunodeficiency Disease and Adenosine Deaminase Deficiency (R. Pickering, B. Pollera, I. Porter, and H. Meuioissen, eds.), Academic Press, New York.Google Scholar
  54. Glasky, A. J., Friedbertshauser, G. E., Holker, J. E., Settineri, R. A., and Ginsberg, T., 1975, The role of cell mediated immunity in the therapeutic action of isoprinosine on viral disease processes: Proc. 9th Int. Congr. Chemother., July 13–18, 1975, Int. Soc. Chemother. 6: 235.Google Scholar
  55. Gordon, O., Ronsen, B., and Brown, E. R., 1974, Anti-herpesvirus action of isoprinosine, Antimicrob. Agents Chemother. 5:153.PubMedCrossRefGoogle Scholar
  56. Greenberg, S. B., Criswell, B. S., Six, H. R., and Couch, R. B., 1977, Lymphocyte cytotoxicity to influenza virus infected cells. II. Requirement for antibody and non-T lymphocytes, J. Immunol. 119:2100.PubMedGoogle Scholar
  57. Greenberg, S. B., Criswell, S., Six, H. R., and Couch, R.B., 1978, Lymphocyte cytotoxicity to influenza virus infected cells: Response to vaccination and virus infection, Infect. Immun. 20:640.PubMedGoogle Scholar
  58. Gutekunst, D. E., Paton, I. M., and Volance, F. J., 1969, Parainfluenza 3 vaccine in cattle: Comparative efficacy of intranasal and intramuscular, J. Am. Vet. Med. Assoc. 155:1879.PubMedGoogle Scholar
  59. Gwaltney, J. M., 1970, Rhinovirus inhibition by 3-substituted triazinoindoles, Proc. Soc. Exp. Biol. Med. 133:1148.PubMedGoogle Scholar
  60. Gwaltney, J. M., Jr., Hendley, J. O., Simon, G., and Jordan, W. S., Jr., 1967, Rhinovirus infection in an industrial population. II Characteristics of illness and antibody responses, J. Am. Med. Assoc. 202:494.CrossRefGoogle Scholar
  61. Hadden, J. W., Hadden, E. M., and Coffey, R. G., 1976, Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation, Infect. Immun. 13:382.PubMedGoogle Scholar
  62. Hambling, M. H., 1964, A survey of antibodies to respiratory syncytial virus in the population, Br. Med. J. 1:1223.PubMedCrossRefGoogle Scholar
  63. Hamparian, V. V., Leagus, M. B., Hilleman, M. R., and Stokes, J., Jr., 1964, Epidemiologic investigations of rhinovirus infections, Proc. Soc. Exp. Biol. Med. 117:469.Google Scholar
  64. Hamre, D., 1968, Rhinoviruses, pp. 59–79, Karger, Basel/ New York.Google Scholar
  65. Hanson, R. J., Kempf, J. E., and Board, A. V., Jr., 1957, Phagocytosis of influenza virus. IL Its occurrence in normal and immune mice, J. Immunol. 79:422.Google Scholar
  66. Harnett, G. B., and Hooper, W. L., 1968, Test tube organ cultures of ciliated epithelium for the isolation of respiratory viruses, Lancet 1:339.PubMedCrossRefGoogle Scholar
  67. Henderson, F. W., Collier, A. N., Clyde, W. A., and Denny, F. W., 1979, Respiratory syncytial virus infections, reinfections and immunity, N. Engl. J. Med. 300:530.PubMedCrossRefGoogle Scholar
  68. Henle, W., and Lief, F. S., 1963, The broadening of antibody spectra following multiple exposure to influenza viruses, Am. Rev. Resp. Dis. 88:379.PubMedGoogle Scholar
  69. Henney, C. S., and Waldman, R. H., 1970, Cell-mediated immunity shown by lymphocytes from the respiratory tract, Science 169:696.PubMedCrossRefGoogle Scholar
  70. Hibbs, J. B., Lambert, L. H., and Remington, J. S., 1972, In vitro nomimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophage, Proc. Soc. Exp. Biol. Med. 139:1049.PubMedGoogle Scholar
  71. Hodes, D. S., Kim, H. W., Parrott, R. H., Camargo, E. E., and Chanock, R. M., 1974, Genetic alteration in a temperature sensitive mutant of respiratory syncytial virus after replication in vivo, Proc. Soc. Exp. Biol. Med. 145:1158.Google Scholar
  72. Jackson, G. G., and Muldoon, R. L., 1973, Viruses causing common respiratory infection in man. IV. Reo viruses and adenoviruses, J. Infect. Dis. 128:834.Google Scholar
  73. Jackson, G. G., and Muldoon, R. L., 1975, Viruses causing common respiratory infections in man. V. Influenza A (Asian), J. Infect. Dis. 131:308.PubMedCrossRefGoogle Scholar
  74. Johnson, K. M., Chanock, R. M., Riflcind, D., Kravetz, H. M., and Knight, V., 1961, Respiratory syncytial virus. IV. Correlation of virus shedding, serologic response and illness in adult volunteers, J. Am. Med. Assoc. 176:663.CrossRefGoogle Scholar
  75. Jurgensen, P. R., Olsen, G. N., Johnson, J. E., III, Swenson, E. W., Ayoub, E. M., Henney, G. S., and Waldman, R. H., 1973, Immune response of the human respiratory tract. II. Cell mediated immunity in the lower respiratory tract to tuberculin and mumps and influenza viruses, J. Infect. Dis. 128:730.PubMedCrossRefGoogle Scholar
  76. Kaltreider, H. B., 1976, Expression of immune mechanisms in the lung. Am. Rev. Respir. Dis. 113:347.PubMedGoogle Scholar
  77. Kapikian, A. Z., Mitchell, R. H., Ghanock, R. M., Shevedoff, R. A., and Stewart, G. E., 1969a, An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405.PubMedGoogle Scholar
  78. Kapikian, A. Z., James, H. D., Kelly, S. J., Dees, J., Turner, H. G., Mcintosh, K., Kun, H. W., Parrott, R. H., Vincent, M., and Ghanock, R. M., 1969b, Isolation from man of “avian infectious bronchitis-like” viruses (coronaviruses) similar to 229E viruses, with some epidemiological observations, J. Infect. Dis. 119:282.PubMedCrossRefGoogle Scholar
  79. Kapikian, A. Z., James, H. D., Kelly, S. J., King, L. M., Vaughn, A. L., and Ghanock, R. M, 1972, Hemabsorption by coronavirus strain OC43, Proc. Soc. Exp. Biol. Med. 139:179.PubMedGoogle Scholar
  80. Kasel, J. A., 1969, Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine, J. Immunol. 102:555.PubMedGoogle Scholar
  81. Kasel, J. A., et al., 1966, Adenovirus soluble antigens for human immunization—a progress report. Am. Rev. Resp. Dis. 94:170.Google Scholar
  82. Kaur, J., McGhee, J. R., and Burrows, W., 1972, Immunity to cholera: The occurrence and nature of antibody-active immunoglobulins in the lower ileum of the rabbit, J. Immunol. 108:387.PubMedGoogle Scholar
  83. Kaye, H. S., and Dowdle, W. R., 1969, Some characteristics of hemagglutination of certain strains of ‘TBV Like’ viruses, J. Infect. Dis. 120:576.PubMedCrossRefGoogle Scholar
  84. Kaye, H. S., Ong, S. B., and Dowdle, W. R., 1972, Detection of coronaviruses 229E antibody by indirect-hem- agglutination, Appl. Microbiol. 24:703.PubMedGoogle Scholar
  85. Kilbourne, E. D., Laver, W. G., Schulman, J. L., and Webster, R. G., 1968, Antiviral activity of antiserum specific for an influenza virus neuraminidase, J. Virol. 2:281.PubMedGoogle Scholar
  86. Kilbourne, E. D., et al., 1972, Influenza virus polypeptides and antigens. Summary of workshop I, J. Infect. Dis. 125:447.CrossRefGoogle Scholar
  87. Kim, H. W., Gonchola, J. G., Vargosko, A. J., Arrobio, J. O., DeMeio, J. L., and Parrott, R. H., 1966, Immunogenicity of inactivated parainfluenza type 1, type 2 and type 3 vaccines in infants, J. Am. Med. Assoc. 196:819.CrossRefGoogle Scholar
  88. Kim, H. W., Arrobio, J. O., Brandt, G. D., Wright, P., Hodes, D., Ghanock, R. M., and Parrott, R. H., 1973, Safety and antigenicity of temperature sensitive (ts) mutant respiratory synctial (RS) virus in infants and children. Pediatrics 52:56.PubMedGoogle Scholar
  89. Knight, V., 1973, Airborne transmission and pulmonary deposition of respiratory viruses, in: Viral and Mycoplasmal Infections of the Respiratory Tract (V. Knight, ed.), pp. 1–9, Lea and Febiger, Philadelphia.Google Scholar
  90. Knopf, H. L. S., Bertrán, D. M., and Kapikian, A. Z., 1970, Demonstration and characterization of antibody in tears following intranasal vaccination with inactivated type 13 rhinovirus. A preliminary report. Invest. Ophthalmol. 9:727.PubMedGoogle Scholar
  91. Kravetz, H. M., Knight, V., Ghanock, R. M., Morris, J. A., Johnson, K. M., Rifkind, D., and Utz, J. P., 1961, Respiratory syncytial virus. III. Production of illness and clinical observations in volunteers, J. Am. Med. Assoc. 176:657–663.Google Scholar
  92. Krizanova, O., and Rathova, V., 1969, Serum inhibitors of myxoviruses, Curr. Top. Microbiol. Immunol. 47:125.PubMedCrossRefGoogle Scholar
  93. Lee, J. D., Khakoo, R. A., Street, G. K., and Waldman, R. H., 1977, An attenuated influenza viruse vaccine: Protection against homologous and heterologous strains of virus, J. Infect. Dis. 135:824.PubMedCrossRefGoogle Scholar
  94. Mackaness, G. B., 1969, The influence of immunologically committed lymphoid cells on macrophage activity in vivo, J. Exp. Med. 129:973.Google Scholar
  95. MackHn, G. G., 1954, Pulmonary sumps, dust accumulations, alveolar fluid and lymph vessels. Acta Anat. 23:1.Google Scholar
  96. Mann, J. J., Waldman, R. H., Togo, Y., Heiner, G. G., Dawkins, A. T., and Kasel, J. A., 1968, Antibody response in respiratory secretions of volunteers inoculated with live and dead influenza virus, J. Immunol. 100:726.PubMedGoogle Scholar
  97. Mclntosh, K., Dees, J. H., Becker, W. B., Kapikian, A. Z., and Chanock, R. M., 1967, Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease, Proc. Natl. Acad. Sci. USA 57:933.CrossRefGoogle Scholar
  98. Mclntosh, K., Kapikian, A. Z., Hardison, K. A., Hartley, J. W., and Chanock, R. M., 1969, Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses, J. Immunol. 102:1109.Google Scholar
  99. Mclntosh, K., Kapikian, A. Z., Turner, H. C., Hartley, J. W., Parrott, R. H., and Ghanock, R. M., 1970, Seroepidemiologic studies of coronavirus infection in adults and children. Am. J. Epidemiol. 91:585.Google Scholar
  100. Morag, A., Beutner, K., Morag, B., and Ogra, P. L., 1974, Secretory and systemic antibody and cell mediated immunity to rubella virus in guinea pigs. Fed. Proc. 33:787.Google Scholar
  101. Morag, A., Morag, B., Bernstein, J. M., Beutner, K., and Ogra, P. L., 1975, In vitro correlates of CMI in human tonsils after natural or induced rubella virus infection, J. Infect. Dis. 131:409.PubMedCrossRefGoogle Scholar
  102. Morrow, P. E., 1972, Lymphatic drainage of the lung in dust clearance, Ann. N.Y. Acad. Sci. 200:46.PubMedCrossRefGoogle Scholar
  103. Mufson, M. A., Ludwig, W. M., James, H. D., Gould, L. W, Rourke, J. A., Holper, J. G., and Chanock, R. M., 1963, Effect of neutralizing antibody on experimental rhinovirus infection, J. Am. Med. Assoc. 186:578.CrossRefGoogle Scholar
  104. Nagaishi, C., 1972, Functional Anatomy and Histology of the Lung, pp. 102–180, University Park Press, Baltimore.Google Scholar
  105. Ogra, P. L., 1971a, The secretory immunoglobulin system of the gastrointestinal tract, in: Conference on the Secretory Immunologic System, Vero Beach, Fla., 1969 (D. H. Dayton, ed.), pp. 259–279, National Institute of Child Health and Human Development, U.S. Government Printing Office, Bethesda, Md.Google Scholar
  106. Ogra, P. L., 1971b, Effect of tonsillectomy and adeno-idectomy on nasopharyngeal antibody response to poliovirus, N. Engl J. Med. 284:59.PubMedCrossRefGoogle Scholar
  107. Ogra, P. L., and Karzon, D. T., 1969, Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine, J. Immunol. 102:15.PubMedGoogle Scholar
  108. Ogra, P. L., and Karzon, D. T., 1971, Formation and function of poliovirus antibody in different tissues, in: Progress in Medical Virology, Vol. 13 (J. L. Melnick, ed.), pp. 156–193, Karger, New York.Google Scholar
  109. Ogra, P. L., Karzon, D. T., Righthand, F., and Mac-Gullivray, M., 1968, Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection, N. Engl. J. Med. 279:893.PubMedCrossRefGoogle Scholar
  110. Ogra, P. K., Kerr-Grant, D., Umana, G., Dzierba, J., and Weintraub, D., 1971, Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus, N. Engl. J. Med. 285:1333.PubMedCrossRefGoogle Scholar
  111. Perkins, J. C., Tucker, D. N., Knopf, H. L. S., Wenzel, R. P., Kapikian, A. Z., and Chanock, R. M., 1969, Comparison of protective effect of neutralizing antibody in serum and in nasal secretions in experimental rhinovirus type 13 illness, Am. J. Epidemiol. 90:519.PubMedGoogle Scholar
  112. Platts-Mills, T. A. E., and Ishizaka, K., 1975, IgG and IgA diphtheria antitoxin responses from human tonsil lymphocytes, J. Immunol. 114:1058.PubMedGoogle Scholar
  113. Pierce, W. E., Rosenbaum, M. J., Edwards, E. A., Peckinpaugh, R. O., and Jackson, G. G., 1968, Live and inactivated adenovirus vaccines for the preventian of acute respiratory illness in normal recruits. Am. J. Epidemiol. 87:237.PubMedGoogle Scholar
  114. Rossen, R. D., and Butler, W. T., 1973, Immunologic responses to infection at mucosal surfaces, in: Viral and Mycoplasmal Infections of the Respiratory Tract (V. Knight, ed.), pp. 23–52, Lea and Febiger, Philadelphia.Google Scholar
  115. Rossen, R. D., Douglas, R. G., Jr., Cate, T. R., Couch, R. B., and Butler, W. T., 1966, The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold, J. Immunol. 97:532.PubMedGoogle Scholar
  116. Rossen, R. D., Butler, W. T., Waldman, R. H., Alford, R. H., Hornick, R. B., Togo, Y., and Kasel, J. A., 1970, ’ The proteins in nasal secretions, J. Am. Med. Assoc. 211:1157.Google Scholar
  117. Rudzik, O., Clancy, R., Perey, D. Y. E., Bienenstock, J., and Singal, D. P., 1975a, The distribution of a rabbit thymic antigen and membrane immunoglobulins in lymphoid tissue with special reference to mucosal lymphocytes, J. Immunol. 114:1.PubMedGoogle Scholar
  118. Rudzik, R., Clancy, R. L., Perey, D. Y. E., Day, R. P., and Bienenstock, J., 1975b, Repopulation with IgA-con-taining cells of bronchial and intestinal lamina propria after transfer of homologous Peyers’ patch and bronchial lymphocytes, J. Immunol. 114:1599.PubMedGoogle Scholar
  119. Schmidt, N. J., and Lennette, E. H., 1971, A comparison of the diagnostic value of adenoviral complement-fixing antigens prepared from various immunotypes, Am. J. Clin. Pathol. 55:34.PubMedGoogle Scholar
  120. Smith, C. B., Purcell, R. H., Bellanti, J. A., and Chanock, R. M., 1966, Protective effect of antibody to parainfluenza type 1 virus, N. Engl. J. Med. 275:1145.PubMedCrossRefGoogle Scholar
  121. Smith, C. B., Bellanti, J. A., and Chanock, R. M., 1967, Immunoglobulins in serum and nasal secretion following infection with type 1 parainfluenza virus and injection of inactivated vaccines, J. Immunol. 99:133.PubMedGoogle Scholar
  122. Sommerville, R. G., 1963, Respiratory syncytial virus in acute or chronic bronchitis, Lancet 2:1247.PubMedCrossRefGoogle Scholar
  123. Stanley, E. D., and Jackson, G. G., 1969, Spread of enteric live adenovirus type 4 vaccine in married couples, J. Infect. Dis. 119:51.PubMedCrossRefGoogle Scholar
  124. Stott, E. J., Probert, M., and Thomas, L. H., 1975, Cytotoxicity of alveolar macrophages for virus infected cells, Nature (London) 225:710.CrossRefGoogle Scholar
  125. Taylor-Robinson, D., and Bynoe, M. L., 1964, Inoculation of volunteers with H rhinoviruses, Br. Med. J. 1:540.PubMedCrossRefGoogle Scholar
  126. Tomasi, T. B., Jr., Tan, E. M., Solomon, A., and Prendergast, R. A., 1965, Characteristics of an immune system common to certain external secretions, J. Exp. Med. 121:101.PubMedCrossRefGoogle Scholar
  127. Turner-Warwick, M., 1975, Clinical aspects of protective immunity of the respiratory tract, Thorax 30:601.PubMedCrossRefGoogle Scholar
  128. Vella, P. P., Weibel, R. E., Woodhawn, A. F., Mascoh, C. C., Leagus, M. B., Ittensohn, O. L., Stokes, J., Jr., and Hilleman, M. R., 1969, Respiratory virus vaccines. VIII. Field evaluation of trivalent parainfluenza virus vaccine among preschool children in families. 1967–1968, Am. Rev. Res. Dis. 99:526.Google Scholar
  129. Von Hayek, H., 1960, The Human Lung, pp. 298–314, Hafner, New York.Google Scholar
  130. Waldman, R. H., and Ganguly, R., 1974, Immunity to infections on secretory surfaces, J. Infect. Dis. 130:419.PubMedCrossRefGoogle Scholar
  131. Waldman, R. H., and Ganguly, R., 1975, Duration of circulating and secretory antibody and cell-mediated immunity following immunization. Int. Symp. on Immunity to infections of the respiratory system in man and animals. Dev. Biol. Stand. 28:273.PubMedGoogle Scholar
  132. Waldman, R. H., and Ganguly, R., 1977, Therapeutic efficiency of isoprinosine in rhinovirus infection, Ann. N.Y.Acad. Sci. 284:153.PubMedCrossRefGoogle Scholar
  133. Waldman, R. H., Kasel, J. A., Fulk, R. V., Togo, Y., Hornick, R. B., Heiner, G. G., Dawkins, A. T., Jr., and Mann, J. J., 1968, Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus, Nature (London) 218:594.CrossRefGoogle Scholar
  134. Waldman, R. H., Wood, S. H., Torrez, E. J., and Small, P. A., 1970a, Influenza antibody response following aerosol administration of inactivated virus, Am. J. Epidemiol. 91:575.Google Scholar
  135. Waldman, R. H., Wigley, F. M., and Small, P. A., Jr., 1970b, Specificity of respiratory secretion antibody against influenza virus, J. Immunol. 105:1477.PubMedGoogle Scholar
  136. Waldman, R. H., Small, P. A., Jr., and Rowe, D. S., 1971, Utilization of the secretory immunologic system for protection against disease, in: Conference on the Secretory Immunologic System, Vero Beach, Fla., 1969 (D. H. Dayton, ed.,), pp. 129–147, National Institute of Ghild Health and Human Development, Bethesda, Md.Google Scholar
  137. Waldman, R. H., Spencer, G. S., and Johnson, J. E., 1972a, Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops. Cell. Immunol. 3:294.PubMedCrossRefGoogle Scholar
  138. Waldman, R. H., Grünspan, R., and Ganguly, R., 1972b, Oral immunization of mice with killed S. typhimurium vaccine. Infect. Immun. 6:58.PubMedGoogle Scholar
  139. Waldman, R. H., Wood, S. H., Torrez, E. J., and Small, P. A., 1973, Influenza antibody response following aerosol administration of volunteers via the respiratory tract. Infect. Immun. 8:497.PubMedGoogle Scholar
  140. Watanabe, T., Yoshizaki, T., and Yamamura, Y., 1974, In vitro antibody formation by human tonsil lymphocytes, J. Immunol. 113:608.PubMedGoogle Scholar
  141. Wigley, F. M., Fruchtman, M. H., and Waldman, R. H., 1970, Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine, N. Engl. J. Med. 283:1250.PubMedCrossRefGoogle Scholar
  142. Wilcox, W. G., and Ginsberg, H. S., 1963, Structure of type 5 adenovirus. I. Antigenic relationship of virus-structural protein to virus-specific antigens from infected cells, J. Exp. Med. 118:295.PubMedCrossRefGoogle Scholar
  143. Yamamoto, K., Anacker, R. L., and Ribi, E., 1970, Macrophage migration inhibition studies with cells from mice vaccinated with cell walls of Mycobacterium bovis BGG: Relationship between inhibitory activity of lung cells and resistance to airborne challenge with Myco bacterium tuberculosis H 37 Rv, Infect. Immun. 1:595PubMedGoogle Scholar
  144. Youmans, G. P., Paterson, P. Y., and Sommers, H. M. eds., 1975, Nonbacterial upper respiratory tract disease in:The biological and clinical basis of infectious diseases, Saunders, Philadelphia.Google Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • R. Ganguly
    • 1
  • R. H. Waldman
    • 2
  1. 1.Departments of Medicine and MicrobiologyWest Virginia University School of MedicineMorgantownUSA
  2. 2.Department of MedicineWest Virginia University School of MedicineMorgantownUSA

Personalised recommendations